Gene Editing and Sickle Cell Treatment

Gene Editing and Sickle Cell Treatment

Assessment

Interactive Video

Biology, Science

9th - 12th Grade

Hard

Created by

Olivia Brooks

FREE Resource

The video discusses the use of CRISPR, a gene-editing tool, in treating sickle cell disease. It highlights the approval of Casgevy, a CRISPR-based therapy, and Lyfgenia, which uses lentiviral vectors. The video explains the mechanisms of these treatments, their effectiveness, and the challenges faced, including high costs and limited accessibility. It emphasizes the potential of CRISPR in medicine and the beginning of its application in patient care.

Read more

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary function of CRISPR in gene editing?

To delete entire chromosomes

To replicate DNA sequences

To precisely cut DNA at specific locations

To create new genes

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is NOT a symptom of sickle cell disease?

High blood pressure

Fever

Vaso-occlusive crises

Anemia

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main advantage of Casgevy over traditional bone marrow transplants?

It can be done at home

It is a one-time treatment

It is less expensive

It requires no donor match

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does Casgevy help in treating sickle cell disease?

By removing sickle-shaped cells

By altering the shape of adult hemoglobin

By reactivating fetal hemoglobin production

By increasing red blood cell count

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What technology does Lyfgenia use for gene editing?

TALENs

Zinc finger nucleases

CRISPR-Cas9

Lentiviral vectors

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential risk associated with Lyfgenia treatment?

Permanent alteration of all body cells

Development of acute myeloid leukemia

Immediate allergic reactions

Increased risk of diabetes

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a major challenge in accessing CRISPR-based treatments like Casgevy?

Unavailability of the technology

Lack of trained medical professionals

Lack of patient interest

High cost and limited treatment centers

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?